Search results
5 days ago · In healthy children with no comorbidities, the absolute risk of critical disease from COVID-19 was 4% (95% confidence interval [CI], 1% to 10%). Compared with no comorbidities, the pooled odds ratio (OR) for critical disease was 3.95 (95% CI, 2.78 to 5.63) for the presence of one comorbidity and 9.51 (95% CI, 5.62 to 16.06) for two or more ...
1 day ago · Frequency. 50–70% of hospitalised COVID-19 cases, 10–30% of non-hospitalised cases, and 10–12% of vaccinated cases [3] Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID-19 infection. Symptoms can last weeks, months or years and are often debilitating. [3]
3 days ago · SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Latest Research and Reviews. The...
3 days ago · The Covid-19 pandemic was the canary in the coal mine. Over 90% of countries experienced disruptions in health services due to Covid-19. The world shut down; millions died; health inequities ...
2 days ago · Target Audience and Goal Statement. This activity is intended for primary care physicians, infectious disease specialists, nurse practitioners, physician assistants, and pharmacists. The goal of this activity is for learners to be better able to implement optimal outpatient treatment strategies for non-hospitalized patients with early COVID-19.
5 days ago · Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Eur Heart J. 2022 Mar 14;43(11):1033-1058. doi: 10.1093/eurheartj/ehab696.
3 days ago · The COVID-19 pandemic, and sequencing of the causative virus SARS-CoV-2 at the beginning of 2020, led to the rapid development of the first approved mRNA vaccines. BioNTech and Moderna in December of the same year obtained approval for their mRNA-based COVID-19 vaccines.
